Clinical Trial

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Study acronym: TWIST-EFS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Study to evaluate the safety and performance of the INNOVALVE system
Protocol Amendment History 1 change
notable Trial sites expanded: 17 -> 20 locations 2026-05-29
Trial Details
NCT Number NCT04919980
Lead Sponsor Edwards Lifesciences
Conditions Mitral Valve Regurgitation (Degenerative or Functional)
Enrollment 65 participants
Start Date 2022-09-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-28